1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Selinexor Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 20 mg
  • 1.3.3 60 mg
• 1.4 Market Analysis by Combination Therapy
  • 1.4.1 Overview: Global Selinexor Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
  • 1.4.2 Combination with proteasome inhibitors
  • 1.4.3 Combination with immunomodulatory drug
• 1.5 Market Analysis by Production Technology
  • 1.5.1 Overview: Global Selinexor Tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
  • 1.5.2 Innovator
  • 1.5.3 Generic
• 1.6 Market Analysis by Sales channels
  • 1.6.1 Overview: Global Selinexor Tablets Consumption Value by Sales channels: 2021 Versus 2025 Versus 2032
  • 1.6.2 Hospital
  • 1.6.3 Retail
  • 1.6.4 Online
• 1.7 Market Analysis by Application
  • 1.7.1 Overview: Global Selinexor Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.7.2 Relapsed Or Refractory Multiple Myeloma
  • 1.7.3 Diffuse Large B-Cell Lymphoma
  • 1.7.4 Acute Myeloid Leukemia
  • 1.7.5 Others
• 1.8 Global Selinexor Tablets Market Size & Forecast
  • 1.8.1 Global Selinexor Tablets Consumption Value (2021 & 2025 & 2032)
  • 1.8.2 Global Selinexor Tablets Sales Quantity (2021-2032)
  • 1.8.3 Global Selinexor Tablets Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Karyopharm Therapeutics
  • 2.1.1 Karyopharm Therapeutics Details
  • 2.1.2 Karyopharm Therapeutics Major Business
  • 2.1.3 Karyopharm Therapeutics Selinexor Tablets Product and Services
  • 2.1.4 Karyopharm Therapeutics Selinexor Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Karyopharm Therapeutics Recent Developments/Updates
• 2.2 Antengene
  • 2.2.1 Antengene Details
  • 2.2.2 Antengene Major Business
  • 2.2.3 Antengene Selinexor Tablets Product and Services
  • 2.2.4 Antengene Selinexor Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Antengene Recent Developments/Updates

3 Competitive Environment: Selinexor Tablets by Manufacturer

• 3.1 Global Selinexor Tablets Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Selinexor Tablets Revenue by Manufacturer (2021-2026)
• 3.3 Global Selinexor Tablets Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Selinexor Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Selinexor Tablets Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Selinexor Tablets Manufacturer Market Share in 2025
• 3.5 Selinexor Tablets Market: Overall Company Footprint Analysis
  • 3.5.1 Selinexor Tablets Market: Region Footprint
  • 3.5.2 Selinexor Tablets Market: Company Product Type Footprint
  • 3.5.3 Selinexor Tablets Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Selinexor Tablets Market Size by Region
  • 4.1.1 Global Selinexor Tablets Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Selinexor Tablets Consumption Value by Region (2021-2032)
  • 4.1.3 Global Selinexor Tablets Average Price by Region (2021-2032)
• 4.2 North America Selinexor Tablets Consumption Value (2021-2032)
• 4.3 Europe Selinexor Tablets Consumption Value (2021-2032)
• 4.4 Asia-Pacific Selinexor Tablets Consumption Value (2021-2032)
• 4.5 South America Selinexor Tablets Consumption Value (2021-2032)
• 4.6 Middle East & Africa Selinexor Tablets Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Selinexor Tablets Sales Quantity by Type (2021-2032)
• 5.2 Global Selinexor Tablets Consumption Value by Type (2021-2032)
• 5.3 Global Selinexor Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Selinexor Tablets Sales Quantity by Application (2021-2032)
• 6.2 Global Selinexor Tablets Consumption Value by Application (2021-2032)
• 6.3 Global Selinexor Tablets Average Price by Application (2021-2032)

7 North America

• 7.1 North America Selinexor Tablets Sales Quantity by Type (2021-2032)
• 7.2 North America Selinexor Tablets Sales Quantity by Application (2021-2032)
• 7.3 North America Selinexor Tablets Market Size by Country
  • 7.3.1 North America Selinexor Tablets Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Selinexor Tablets Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Selinexor Tablets Sales Quantity by Type (2021-2032)
• 8.2 Europe Selinexor Tablets Sales Quantity by Application (2021-2032)
• 8.3 Europe Selinexor Tablets Market Size by Country
  • 8.3.1 Europe Selinexor Tablets Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Selinexor Tablets Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Selinexor Tablets Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Selinexor Tablets Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Selinexor Tablets Market Size by Region
  • 9.3.1 Asia-Pacific Selinexor Tablets Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Selinexor Tablets Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Selinexor Tablets Sales Quantity by Type (2021-2032)
• 10.2 South America Selinexor Tablets Sales Quantity by Application (2021-2032)
• 10.3 South America Selinexor Tablets Market Size by Country
  • 10.3.1 South America Selinexor Tablets Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Selinexor Tablets Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Selinexor Tablets Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Selinexor Tablets Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Selinexor Tablets Market Size by Country
  • 11.3.1 Middle East & Africa Selinexor Tablets Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Selinexor Tablets Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Selinexor Tablets Market Drivers
• 12.2 Selinexor Tablets Market Restraints
• 12.3 Selinexor Tablets Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Selinexor Tablets and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Selinexor Tablets
• 13.3 Selinexor Tablets Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Selinexor Tablets Typical Distributors
• 14.3 Selinexor Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Selinexor Tablets market size was valued at US$ 150 million in 2025 and is forecast to a readjusted size of US$ 364 million by 2032 with a CAGR of 11.0% during review period.
Selinexor Tablets are an oral selective inhibitor of nuclear export. By selectively inhibiting the nuclear export protein XPO1, they promote the accumulation of tumor suppressor proteins in the cell nucleus and restore their tumor-suppressive functions, thereby inducing apoptosis of tumor cells. As the world's first approved XPO1 inhibitor, this drug is mainly indicated for the treatment of hematologic malignancies such as relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma, providing a new targeted therapeutic option for advanced patients who have failed multiple lines of therapy.In 2025, global Selinexor Tablets production reached approximately 35,000 bottles.
As the world's first orally administered selective XPO1 inhibitor approved globally, selinexor occupies an important and differentiated market position in the field of relapsed and refractory hematologic malignancies by virtue of its unique mechanism of action. Its core market value lies in providing a breakthrough therapeutic option for advanced patients who have failed multiple lines of treatment and developed resistance to conventional regimens, effectively addressing the unmet clinical needs. Worldwide, the drug has achieved broad market access and continuously improves its accessibility and market penetration through ongoing expansion of indications, advancement of combination therapies, and inclusion in the medical insurance systems of multiple countries. The current market landscape is characterized by dominance of the originator product and regional exclusive licensing and distribution, while facing challenges including generic competition, research and development competition from drugs targeting the same target, and promotion difficulties caused by safety management. In the long run, its market potential highly depends on the successful expansion of indications into the field of solid tumors, optimization of administration regimens, and deepening of the global commercialization network. The drug is in a critical growth stage transitioning from a niche orphan drug to a broad-spectrum targeted therapy, with both opportunities and challenges coexisting.
This report is a detailed and comprehensive analysis for global Selinexor Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Selinexor Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Selinexor Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Selinexor Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Selinexor Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Selinexor Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Selinexor Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Karyopharm Therapeutics, Antengene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Selinexor Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg
60 mg
Market segment by Combination Therapy
Combination with proteasome inhibitors
Combination with immunomodulatory drug
Market segment by Production Technology
Innovator
Generic
Market segment by Sales channels
Hospital
Retail
Online
Market segment by Application
Relapsed Or Refractory Multiple Myeloma
Diffuse Large B-Cell Lymphoma
Acute Myeloid Leukemia
Others
Major players covered
Karyopharm Therapeutics
Antengene
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Selinexor Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Selinexor Tablets, with price, sales quantity, revenue, and global market share of Selinexor Tablets from 2021 to 2026.
Chapter 3, the Selinexor Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Selinexor Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Selinexor Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Selinexor Tablets.
Chapter 14 and 15, to describe Selinexor Tablets sales channel, distributors, customers, research findings and conclusion.